Literature DB >> 25935922

Loperamide dependence and abuse.

Ryan MacDonald1, Jason Heiner2, Joshua Villarreal3, Jared Strote2.   

Abstract

Loperamide is a common over-the-counter antidiarrheal considered safe in a broad range of dosages and thought devoid of abuse potential. We describe the first case of a patient with loperamide dependence due to misuse of its opiate-like effects achieved by chronic massive oral ingestions. A 26-year-old man who was taking 800 mg of loperamide per day presented requesting detoxification referral. Loperamide has potential for euphoric effects and information on how to facilitate such effects is easily available. It is important for physicians to be aware of the potential for misuse of and dependence on loperamide, with symptoms mimicking opiate use. 2015 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25935922      PMCID: PMC4434293          DOI: 10.1136/bcr-2015-209705

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  18 in total

1.  Loperamide dependence.

Authors:  M A Hill; F C Greason
Journal:  J Clin Psychiatry       Date:  1992-12       Impact factor: 4.384

Review 2.  Loperamide.

Authors:  Claud Regnard; Robert Twycross; Mary Mihalyo; Andrew Wilcock
Journal:  J Pain Symptom Manage       Date:  2011-06-23       Impact factor: 3.612

3.  Cardiac conduction disturbance after loperamide abuse.

Authors:  J M Marraffa; M G Holland; R W Sullivan; B W Morgan; J A Oakes; T J Wiegand; M J Hodgman
Journal:  Clin Toxicol (Phila)       Date:  2014-11       Impact factor: 4.467

4.  Loperamide in "toddler diarrhoea".

Authors:  H Marcovitch
Journal:  Lancet       Date:  1980-06-28       Impact factor: 79.321

5.  Loperamide in childhood diarrhoea.

Authors:  J Heap; A Macnair
Journal:  Lancet       Date:  1980-05-17       Impact factor: 79.321

6.  Antinociceptive effect of intrathecal loperamide: role of mu-opioid receptor and calcium channels.

Authors:  Rakesh Kumar; K H Reeta; Subrata Basu Ray
Journal:  Eur J Pharmacol       Date:  2012-09-26       Impact factor: 4.432

7.  Dependence liability of two antidiarrheals, nufenoxole and loperamide.

Authors:  A Korey; D H Zilm; E M Sellers
Journal:  Clin Pharmacol Ther       Date:  1980-05       Impact factor: 6.875

8.  Surveillance of loperamide ingestions: an analysis of 216 poison center reports.

Authors:  T Litovitz; C Clancy; B Korberly; A R Temple; K V Mann
Journal:  J Toxicol Clin Toxicol       Date:  1997

9.  Central analgesic actions of loperamide following transient permeation of the blood brain barrier with Cereport (RMP-7).

Authors:  D F Emerich; P Snodgrass; M Pink; F Bloom; R T Bartus
Journal:  Brain Res       Date:  1998-08-10       Impact factor: 3.252

Review 10.  Herbal modulation of P-glycoprotein.

Authors:  Shufeng Zhou; Lee Yong Lim; Balram Chowbay
Journal:  Drug Metab Rev       Date:  2004-02       Impact factor: 4.518

View more
  5 in total

Review 1.  Diels-Alder Adducts of Morphinan-6,8-Dienes and Their Transformations.

Authors:  János Marton; Anikó Fekete; Paul Cumming; Sándor Hosztafi; Pál Mikecz; Gjermund Henriksen
Journal:  Molecules       Date:  2022-04-30       Impact factor: 4.927

Review 2.  When good times go bad: managing 'legal high' complications in the emergency department.

Authors:  Charles R Caffrey; Patrick M Lank
Journal:  Open Access Emerg Med       Date:  2017-12-20

3.  Comparison of a New Intranasal Naloxone Formulation to Intramuscular Naloxone: Results from Hypothesis-generating Small Clinical Studies.

Authors:  B T Gufford; G R Ainslie; J R White; M E Layton; J M Padowski; G M Pollack; M F Paine
Journal:  Clin Transl Sci       Date:  2017-05-23       Impact factor: 4.689

4.  Is there such a thing as a 'lope' dope? Analysis of loperamide-related European Medicines Agency (EMA) pharmacovigilance database reports.

Authors:  Fabrizio Schifano; Stefania Chiappini
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240

Review 5.  Pharmacological Aspects of Over-the-Counter Opioid Drugs Misuse.

Authors:  Łukasz Sobczak; Krzysztof Goryński
Journal:  Molecules       Date:  2020-08-27       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.